Simon Haas
Overview
Explore the profile of Simon Haas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
3145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maatz H, Lindberg E, Adami E, Lopez-Anguita N, Perdomo-Sabogal A, Cocera Ortega L, et al.
Nat Cardiovasc Res
. 2025 Feb;
PMID: 39994453
Myocarditis, characterized by inflammatory cell infiltration, can have multiple etiologies, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or, rarely, mRNA-based coronavirus disease 2019 (COVID-19) vaccination. The underlying cellular...
2.
Lutz R, Poos A, Sole-Boldo L, John L, Wagner J, Prokoph N, et al.
Sci Immunol
. 2025 Feb;
10(104):eadp6667.
PMID: 39919199
The bone marrow microenvironment plays a crucial role in the development of multiple myeloma. As the disease progresses, malignant myeloma cells can evolve to survive outside the bone marrow. However,...
3.
Lutz R, Grunschlager F, Simon M, Awwad M, Bauer M, Yousefian S, et al.
Nat Commun
. 2024 Nov;
15(1):10396.
PMID: 39613747
The long-term consequences of cancer and its therapy on the patients' immune system years after cancer-free survival remain poorly understood. Here, we present an in-depth characterization of the bone marrow...
4.
Kobbe G, Bruggemann M, Baermann B, Wiegand L, Trautmann H, Yousefian S, et al.
N Engl J Med
. 2024 Nov;
391(13):1217-1226.
PMID: 39589371
The development of a fatal, clonal, autonomously proliferating CD4-CD8- chimeric antigen receptor (CAR)+ peripheral T-cell lymphoma (PTCL) occurred 1 month after a patient received treatment with tisagenlecleucel for relapsed primary...
5.
Yanai I, Haas S, Lippert C, Kretzmer H
Nature
. 2024 Nov;
635(8039):553-555.
PMID: 39567780
No abstract available.
6.
Derigs P, Schubert M, Dreger P, Schmitt A, Yousefian S, Haas S, et al.
Leukemia
. 2024 Aug;
38(11):2419-2428.
PMID: 39192036
Third-generation chimeric antigen receptor T cells (CARTs) for relapsed or refractory (r/r) chronic lymphocytic leukemia (CLL) may improve efficacy compared to second-generation CARTs due to their enhanced CAR design. We...
7.
Carrasco-Zanini J, Pietzner M, Davitte J, Surendran P, Croteau-Chonka D, Robins C, et al.
Nat Med
. 2024 Jul;
30(9):2489-2498.
PMID: 39039249
For many diseases there are delays in diagnosis due to a lack of objective biomarkers for disease onset. Here, in 41,931 individuals from the United Kingdom Biobank Pharma Proteomics Project,...
8.
Ramberger E, Sapozhnikova V, Ng Y, Dolnik A, Ziehm M, Popp O, et al.
Nat Cancer
. 2024 Jun;
5(8):1267-1284.
PMID: 38942927
Multiple myeloma (MM) is a plasma cell malignancy of the bone marrow. Despite therapeutic advances, MM remains incurable, and better risk stratification as well as new therapies are therefore highly...
9.
Baumgartner F, Bamopoulos S, Faletti L, Hsiao H, Holz M, Gonzalez-Menendez I, et al.
Sci Signal
. 2024 Feb;
17(824):eadc9662.
PMID: 38377177
The IL-6-gp130-STAT3 signaling axis is a major regulator of inflammation. Activating mutations in the gene encoding gp130 and germline gain-of-function mutations in STAT3 (STAT3) are associated with multi-organ autoimmunity, severe...
10.
Winkler I, Tolkachov A, Lammers F, Lacour P, Daugelaite K, Schneider N, et al.
Cell
. 2024 Feb;
187(4):981-998.e25.
PMID: 38325365
The female reproductive tract (FRT) undergoes extensive remodeling during reproductive cycling. This recurrent remodeling and how it shapes organ-specific aging remains poorly explored. Using single-cell and spatial transcriptomics, we systematically...